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a  b  s  t  r  a  c  t
Thyroid  hormone  (TH)  target  cells  need  to adopt  mechanisms  to maintain  sufﬁcient  levels  of  TH to
ensure  regular  functions.  This  includes  thyroid  epithelial  cells,  which  generate  TH  in addition  to  being
TH-responsive.  However,  the  cellular  and  molecular  pathways  underlying  thyroid  auto-regulation  are
insufﬁciently  understood.  In order  to  investigate  whether  thyroglobulin  processing  and  TH  export  are
sensed  by thyrocytes,  we  inactivated  thyroglobulin-processing  cathepsins  and  TH-exporting  monocar-
boxylate  transporters  (Mct)  in  the  mouse.  The  states  of thyroglobulin  storage  and  its protease-mediated
processing  and  degradation  were  related  to the  levels  of  TH  transporter  molecules  by immunoblotting  and
immunoﬂuorescence  microscopy.  Thyroid  epithelial  cells  of  cathepsin-deﬁcient  mice showed  increased
Mct8  protein  levels  at the  basolateral  plasma  membrane  domains  when  compared  to  wild  type  controls.
While  the  protein  amounts  of  the  thyroglobulin-degrading  cathepsin  D  remained  largely  unaffected  by
Mct8  or  Mct10  single-deﬁciencies,  a signiﬁcant  increase  in  the  amounts  of  the  thyroglobulin-processing
cathepsins  B and  L  was  detectable  in  particular  in  Mct8/Mct10  double  deﬁciency.  In addition,  it was
observed  that larger  endo-lysosomes  containing  cathepsins  B, D, and  L  were  typical  for Mct8-  and/or
Mct10-deﬁcient  mouse  thyroid  epithelial  cells.  These  data  support  the  notion  of  a crosstalk  between
TH  transporters  and  thyroglobulin-processing  proteases  in  thyroid  epithelial  cells.  We  conclude  that  a
defect  in  exporting  thyroxine  from  thyroid  follicles  feeds  back  positively  on  its  cathepsin-mediated  prote-
olytic liberation  from  the  precursor  thyroglobulin,  thereby  adding  to the  development  of  auto-thyrotoxic
states  in  Mct8 and/or  Mct10  deﬁciencies.  The  data  suggest  TH  sensing  molecules  within  thyrocytes  that
contribute  to thyroid  auto-regulation.
© 2017  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Thyroid dysfunctions caused by altered thyroid hormone (TH)2
generation or disturbed TH action are considered to be among the
most frequent endocrine disorders (Brix et al., 2011; Führer et al.,
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thyroid hormones; TRH, thyrotropin-releasing hormone; TSH, thyroid stimulating
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2015). TH are of crucial importance for the proper functioning of
nearly every organ, including the thyroid gland itself. Hence, all TH
target cells need to adopt mechanisms to maintain sufﬁcient levels
of TH to ensure regular functions. Since the thyroid gland itself not
only produces TH but also responds to TH levels in a self-sustaining
manner, auto-protection of the thyroid gland is vital not only for
thyrocytes but also for all other TH-dependent cells. Proper thyroid
states of an organism are centrally regulated by the hypothalamus-
pituitary-thyroid (HPT)–axis, whereby low serum TH levels trigger
hypothalamic thyrotropin-releasing hormone (TRH) release which
then promotes release of thyroid stimulating hormone (TSH) from
the pituitary (Fliers et al., 2014), thereby triggering TH generation
in the thyroid gland, and TH release into the blood.
To fulﬁll and maintain its tasks, the thyroid gland is composed
of functional units, the so-called thyroid follicles, that are built by
http://dx.doi.org/10.1016/j.ejcb.2017.02.002
0171-9335/© 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Table  1
Speciﬁc functions of different cathepsins expressed in the thyroid regarding their processing of Tg.
extracellular Tg
solubilisation from
cross-linked
storage forms
extracellular Tg
processing
intracellular
limited Tg
processing
(endosomal)
intracellular Tg
degradation
(lysosomal)
direct T4 liberation
from Tg
exhaustive Tg
degradation for Tg
utilization
(endo-lysosomal TH
liberation)
References
Cathepsin B x x x x involved to major
extent
Brix et al., 1996; Dunn
et al., 1996; Tepel et al.,
2000; Friedrichs et al.,
2003; Jordans et al.,
2009
Cathepsin D x involved to minor
extent
Brix et al., 1996; Dunn
et al., 1996; Friedrichs
et al., 2003
Cathepsin K x x x Tepel et al., 2000;
Friedrichs et al., 2003;
Jordans et al., 2009
Cathepsin L x x x x involved to major
extent
Brix et al., 1996; Dunn
et al., 1996; Tepel et al.,
2000; Friedrichs et al.,
2003; Jordans et al.,
2009
Fig. 1. Cathepsin-mediated solubilization, processing, and degradation of Tg.
Schematic drawing summarizing the sequential steps of Tg processing and degradation by endo-lysosomal cathepsins (Brix et al., 1996; Tepel et al., 2000; Brix et al., 2001;
Linke  et al., 2002a; Friedrichs et al., 2003; Jordans et al., 2009; Dauth et al., 2011). Cathepsins B and L involve in extracellular Tg solubilization from its covalently cross-linked
storage  forms, while cathepsin K is instrumental in Tg utilization for T4 liberation. Upon re-internalization of intact and partially degraded Tg, it is further processed and
degraded by aspartic and cysteine cathepsins within endo-lysosomes of thyrocytes.
a monolayer of thyroid epithelial cells (Fujita, 1988; Nilsson and
Fagman, 2013). The macromolecular TH precursor thyroglobulin
(Tg) is stored in covalently cross-linked form in the extracellu-
lar thyroid follicle lumen (Herzog et al., 1992; Berndorfer et al.,
1996; Klein et al., 2000; Saber-Lichtenberg et al., 2000). Covalently
cross-linked Tg is processed for solubilization and degradation by
proteases, which are secreted in a TSH-regulated fashion into the
extra-cellular follicle lumen upon a demand of TH in the body
periphery (for reviews, see Brix et al., 2001; Dauth et al., 2011).
Thus, solubilization of Tg from its covalently cross-linked storage
forms is enabled through limited, extracellular protein processing
facilitated by cathepsins B and L, while TH liberation from Tg is
mediated by cathepsins K and L, and also initiated in the thyroid
follicle lumen (Brix et al., 1996; Linke et al., 2002a; Friedrichs et al.,
2003; Tepel et al., 2000). Subsequently, partially degraded Tg is
internalized and reaches endo-lysosomal compartments, where T3
and T4 liberation is completed for Tg utilization through exhaustive
proteolysis mediated by a variety of hydrolytic enzymes including
aspartic and cysteine cathepsins B, D, K, L, and S (Brix et al., 1996;
Tepel et al., 2000; Linke et al., 2002a; Friedrichs et al., 2003; Jordans
et al., 2009). Cathepsin K is special among the Tg-processing pro-
teases as it is able to liberate T4 directly from Tg (Tepel et al., 2000).
In brief summary, thyroid functions are enabled by sequential pro-
teolytic processing of Tg (Table 1, Fig. 1), resulting in the liberation
of T4 and, to a lower extent, T3.
Considering that thyroid epithelial cells need to release TH
through transmembrane translocation into the blood circulation,
and keeping in mind that thyrocytes are TH target cells themselves,
a regulatory mechanism must exist that determines how much of
the T4 liberated from Tg is either retained in the thyrocytes or
transported back into the same. We  propose that intra-thyroidal
TH transporters like the monocarboxylate transporter molecules
Mct8 and Mct10 may  act as such sensors of (i) the extent of pro-
teolytic TH liberation, (ii) the amounts of TH released from thyroid
follicles, and (iii) the levels of re-uptake of circulating TH back into
thyroid follicles.
Mice with a global Mct8-deﬁciency (Mct8 knock-out mice)
exhibit central TH-resistance, i.e. TRH levels are dramatically ele-
vated despite highly increased serum T3 levels, whereas serum
T4 levels are decreased, and TSH is slightly elevated (Dumitrescu
et al., 2006; Trajkovic et al., 2007; Wirth et al., 2011). This very
unusual thyroid status (Table 2) is in part explained by the fact
that Mct8 is localised at the basolateral plasma membrane domain
of thyroid epithelial cells, and thus, its functional absence in mice
leads to diminished T4 export from thyroid follicles (Trajkovic-Arsic
et al., 2010a,b; Di Cosmo et al., 2010). Moreover, intra-thyroidal
levels of non-Tg-bound and Tg-bound TH are 2- to 3-fold elevated
over WT  in Mct8-deﬁcient mice (Di Cosmo et al., 2010; Trajkovic-
Arsic et al., 2010b; Liao et al., 2011; Muller et al., 2014), which
also feature enlarged thyroid follicles, enhanced thyroid epithelial
extensions, and develop pathological abnormalities like papillary
structures characterized by nuclear alterations, in particular, at
older age (Wirth et al., 2011). Consequently, the Mct8-deﬁcient
mouse thyroid gland is considered to be characterized by auto-
thyrotoxic as well as thyrotoxic states affecting peripheral TH target
organs (for review, see Müller and Heuer, 2014; Heuer and Visser,
2013). The transporter Mct10 (Slc16a10/Tat1) is expressed to much
lower amounts in the thyroid gland but in a pattern similar to Mct8;
however, a lack of Mct10 alone did not alter the serum TH states in
comparison to wild type mice (Mariotta et al., 2012; Muller et al.,
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Table 2
Thyroid function parameters, peripheral and intra-thyroidal thyroid states, TH generation and TH release in Mct8/10-deﬁcient mice.
Mct8−/y Mct10−/− Mct8−/y/Mct10−/− References
Thyroid function parameters, HPT axis
•  serum T4 ↓ = = Dumitrescu et al., 2006; Trajkovic et al., 2007; Di Cosmo et al., 2010;
Liao et al., 2011; Wirth et al., 2011; Trajkovic-Arsic et al., 2010b;
Muller et al., 2014
• serum T3 ↑↑↑ = ↑↑↑ Dumitrescu et al., 2006; Trajkovic et al., 2007; Di Cosmo et al., 2010;
Liao et al., 2011; Wirth et al., 2011; Trajkovic-Arsic et al., 2010b;
Muller et al., 2014
• serum TSH, or TSH
mRNA (pituitary)
↑ = ↑ Dumitrescu et al., 2006; Trajkovic et al., 2007; Trajkovic-Arsic et al.,
2010b; Liao et al., 2011; Wirth et al., 2011; Muller et al., 2014
• TRH mRNA
(hypothalamus)
↑↑ = = Trajkovic et al., 2007; Trajkovic-Arsic et al., 2010b; Muller et al., 2014
peripheral Dio1 activity
(liver, kidney)
↑ = ↑↑ Dumitrescu et al., 2006; Trajkovic et al., 2007; Liao et al., 2011;
Trajkovic-Arsic et al., 2010a; Trajkovic-Arsic et al., 2010b; Muller et al.,
2014
intra-thyroidal thyroid states
•  intra-thyroidal TH
•  (non-Tg-bound and
Tg-bound)
↑↑ = ↑↑↑ Di Cosmo et al., 2010; Trajkovic-Arsic et al., 2010b; Liao et al., 2011;
Muller et al., 2014
• intra-thyroidal Dio1
activity
= Di Cosmo et al., 2010; Wirth et al., 2011; Muller et al., 2014
• auto-thyrotoxic state, i.e.
papillary structures with
nuclear changes; or
altered tumour marker
like Galectin-3
↑↑ = ↑↑↑ Wirth et al., 2011; Muller et al., 2014
• thyroid follicle and/or
luminal areas
↑ = ↑↑ Di Cosmo et al., 2010; Trajkovic-Arsic et al., 2010b; Wirth et al., 2011;
Muller et al., 2014
• thyroid epithelial
extensions
↑ Di Cosmo et al., 2010; Wirth et al., 2011
TH generation
• Nis (sodium iodide
symporter), Ttf1
(transthyretin)
↑ not signiﬁ-cant = ↑↑ Di Cosmo et al., 2010; Muller et al., 2014
• Tshr (TSH receptor), Tpo
(thyroid peroxidase), Tg
(thyroglobulin), Dehal1
(dehalogenase 1)
= = ↑↑ Di Cosmo et al., 2010; Trajkovic-Arsic et al., 2010b; Muller et al., 2014
TH release from thyroid follicles
•  TSH-stimulated T4
release
↓ Di Cosmo et al., 2010; Trajkovic-Arsic et al., 2010b
• TSH-stimulated T3
release
↑ Trajkovic-Arsic et al., 2010b
• Mct10,  Lat1, Lat2 (TH
transporters)
= Di Cosmo et al., 2010
2014). Interestingly, mice deﬁcient in both Mct8 and Mct10 pro-
teins (Muller et al., 2014) showed a partial rescue of the unusual
serum TH status observed in Mct8-deﬁcient animals, whereas the
intra-thyroidal auto-thyrotoxic states were even more pronounced
than in Mct8 deﬁciency alone. Therefore, both Mct8 and Mct10
appear to be responsible for TH export from thyrocytes (Muller
et al., 2014).
The astonishing changes in tissue-speciﬁc TH states in mice with
TH transporter-deﬁciencies indicate that TH levels are regulated
in an organ-speciﬁc manner, and not entirely governed by sys-
temic factors such as regulation through the HPT axis. With regard
to the thyroid gland itself, such organ-speciﬁc mechanisms must
comprise of intra-thyroidal self-regulatory pathways to manage its
thyroid state. In this study, pathways of thyroid auto-regulation
were studied in Mct8- and/or Mct10-deﬁcient male mice in com-
parison to wild type (WT) controls. In addition, Ctsk−/− male mice
were used, because they provide a suitable animal model for
analyzing intra-thyroidal pathways of thyroid auto-regulation, in
particular with regard to Tg proteolysis (Dauth et al., 2011). Serum
TH levels are not altered in cathepsin K deﬁciency, and hence,
TSH levels are likely not enhanced in this mouse model, despite
developing an enlarged thyroid gland and featuring changes in Tg-
processing abilities in that cathepsin L is up-regulated (Friedrichs
et al., 2003). This means that Ctsk−/− mice show signs of thyroid
dysfunction without an accompanying dysregulation of the HPT
axis. Thus, the main objective of this study is to elucidate cellu-
lar and molecular pathways underlying auto-regulation of thyroid
functions in animals with functional defects in Tg-processing and
in TH release from thyroid follicles.
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2. Materials and methods
2.1. Animals
All studies were performed with 10–14 weeks and 20–28
weeks old male Ctsk−/−, Mct8−/y, Mct10−/−, Mct8−/y/Mct10−/− or
WT  C57Bl/6J mice. The mice were back-crossed to a congenic
C57Bl/6J background in the animal facility of Jacobs University Bre-
men, Germany, licenced under SfAFGJS Az. 513-30-00/2-15-32 and
522-27-11/3-1, 05-A20 and A21. The generation and genotyping
procedures of mouse strains lacking Mct8 (Trajkovic et al., 2007;
Wirth et al., 2009), Mct10 (Mariotta et al., 2012), Mct8 and Mct10
(Muller et al., 2014), or Ctsk (Saftig et al., 1998) were described
previously. Ctsb−/−, Ctsk−/−, Ctsl−/−, and Ctsb−/−/Ctsk−/− male mice
were bred and housed as previously described (Friedrichs et al.,
2003). In general, mice were housed under standard conditions,
with a 12 h/12 h light/dark cycle with lights out at 07:00 p.m. and
ad libitum water and food.
2.2. Tissue sampling and sectioning
Mice were deeply anesthetized by CO2 inhalation or by using the
inhalation-anesthetic IsoFlou (Abbott GmbH & Co. KG, Wiesbaden-
Delkenheim, Germany) before intra-peritoneal injection of 100 l
of 10% ketamine (CEVA Sante Animale, Düsseldorf, Germany). The
abdominal and thoracic cavities were opened and the abdomi-
nal aorta was cut. Perfusion was carried out through the heart
with 0.9% NaCl supplemented with 200 IU heparin (Braun Mel-
sungen AG, Melsungen, Germany). The thyroid was immediately
removed, while still attached to the trachea, either snap-frozen
in liquid nitrogen, or incubated in 4% PFA in 200 mM HEPES, pH
7.4, and left overnight at 4 ◦C. Then, cryo-preservation was car-
ried out by embedding in Tissue Freezing Medium (Jung, through
Leica Microsystems, Wetzlar, Germany) overnight, before tissue
was frozen in the gas phase of liquid nitrogen and stored at -
80 ◦C until sectioning. Thyroid samples were then mounted on the
sectioning tableau of the cryotome, and sections of 5 m were pre-
pared at −20 ◦C (Leica Microsystems).
2.3. Indirect immunoﬂuorescence
Embedding material was washed out of the tissue sections
with PBS prior to the staining procedure. Blocking was  performed
with 3% bovine serum albumin (Albumin Fraction V, Roth, Karl-
sruhe, Germany) for 60 min  at 37 ◦C. Samples were incubated
overnight with speciﬁc antibodies diluted in 0.1% BSA in calcium-
and magnesium-free PBS (CMF-PBS) at 4 ◦C in a moisturized cham-
ber. Speciﬁc antibodies were rabbit anti-Mct8 (HPA003353; 1 in
250 ATLAS Antibodies, Stockholm, Sweden), sheep anti-cathepsin
L (06-0008; 1 in 20, RD antibodies through Merck-Millipore,
Darmstadt, Germany), goat anti-cathepsin B (GT15047; 1 in 200,
Neuromics, through Acris, Himmelstadt, Germany), sheep anti-
cathepsin D (06-0003; 1 in 50, Bio-Ass, Diessen, Germany), and
rabbit anti-bovine Tg (Brix et al., 1998). Secondary antibodies and
counter-stains were incubated for 60 min  at 37 ◦C. As secondary
antibodies, indocarbocyanine- (Cy3) or Alexa488-conjugated goat
anti-rabbit IgG, donkey anti-sheep and rabbit anti-goat IgG, and
Alexa Fluor 546 coupled to donkey anti-sheep were used. Draq5TM
(DR05500, 1 in 500, BioStatus, Leicestershire, UK) was  used as
counter-stain to visualize nuclear DNA.
2.4. Image acquisition of mouse thyroid tissue and densitometry
Confocal images were taken using a Zeiss LSM 510 META laser
scanning microscope equipped with Argon and Helium-Neon lasers
(Carl Zeiss Jena GmbH, Jena, Germany). Optical sections were taken
with a pinhole opening of 1 Airy unit and at a resolution of
1024 × 1024 pixels or 2048 × 2048, using LSM 5 software (version
3.2; Carl Zeiss GmbH). For quantitation of cysteine cathepsin and
Mct8 levels, thyroid tissue from at least three different animals was
analyzed such that images from tissue sections were obtained at
the same detector gain and pinhole settings. The number of fol-
licles analyzed is given in the respective ﬁgure legends. By using
Cell Proﬁler software, signals of immunostaining intensities were
quantiﬁed and normalized to the number of cells by enumerat-
ing the corresponding Draq5TM-positive nuclei (Kamentsky et al.,
2011).
2.5. Protein extraction
Thyroid tissue samples were homogenized and lysed in ice-
cold PBS containing 0.5% Triton X-100, 1 mM EDTA, and protease
inhibitors (0.2 g/ml aprotinin, Sigma-Aldrich, 1153; EDTA; 10 M
E-64, Enzo Life Science, Farmingdale, NY, USA, ALX 260007-
M005; 1 M pepstatin A, Sigma-Aldrich, 77170). After clearing at
10,000 × g and 4 ◦C for 10 min, the lysates were stored at −20 ◦C. The
protein content of all samples was  determined using the Neuhoff
assay (Neuhoff et al., 1979) as described before (Arampatzidou et al.,
2012).
2.6. Gel electrophoresis and immunoblotting
Tissue lysates were normalized to equal amounts of pro-
tein, heated at 95 ◦C in sample buffer and separated on self-cast
12.5% acrylamide gels or horizontal SDS Gradient 8–18 Excel-
Gel gels (GE Healthcare, Uppsala, Sweden). In some experiments,
proteins of tissue lysates were separated under non-reducing con-
ditions. Gels were either stained for total protein by silver staining
(Heukeshoven and Dernick, 1988), or separated proteins were fur-
ther transferred onto a nitrocellulose membrane by a semi-dry
blotting procedure (Kyhse-Andersen, 1984).
Immunodetection was  performed with primary antibodies rab-
bit anti-ß-tubulin (ab6046, 1 in 500, Abcam), goat anti-cathepsin B
(GT15047; 1 in 1000, Neuromics through Acris, Herford, Germany),
rabbit anti-cathepsin D (IM16; 1 in 80, Calbiochem through Merck
Millipore), goat anti-cathepsin L (GT15049; 1 in 1000, Neuromics
through Acris), rabbit anti-Mct8 (HPA003353; 1 in 2500 ATLAS
Antibodies), and rabbit anti-bovine Tg (W.S. 3, Brix et al., 1998)
applied for 1.5 h (see, Friedrichs et al., 2003). The respective sec-
ondary antibodies, HRP-conjugated goat anti-rabbit IgG (H + L sp.)
and rabbit anti-goat IgG (H + L sp.) were applied for 1 h at room tem-
perature. Visualization was performed by chemiluminescence ECL
Western Blotting substrate onto XPosureTM ﬁlm (Pierce through
Thermo Scientiﬁc, Schwerte, Germany), which were scanned using
a transmitted light scanner device. Densitometry analyses were
performed by using ImageJ as described elsewhere (Tan and Ng,
2008; Gassmann et al., 2009). Samples were normalized to equal
amounts of protein and bands were normalized to WT controls or
to ß-tubulin loading if not stated otherwise.
2.7. Statistical analyses
Levels of statistical signiﬁcance of non-paired observations were
calculated by two-tailed Student’s t-test or one-way ANOVA with
Dunnett’s correction for multiple comparisons using Microsoft
®
Excel
®
2016 (Microsoft Corp.) or Graph Pad PrismTM (GraphPad
Software Inc., San Diego, CA, USA).
3. Results
Mice deﬁcient in Mct8 and/or Mct10 are characterized by thy-
rotoxic states in several TH target organs, including the thyroid
gland itself. The two- to three-fold elevated TH levels in thyroid
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tissue of Mct8- and Mct10-double-deﬁcient mice (Muller et al.,
2014) can, in principle, be explained by the inability of thyroid
follicles to properly release TH into the blood stream due to lack-
ing Mct8- and/or Mct10-mediated transport across the basolateral
plasma membrane domain of thyroid epithelial cells, leading to TH
accumulation within these cells. In addition, reduced T4 levels in
the blood stream stimulate TSH production, in principle, possibly
affecting Tg solubilization and utilization by means of its extra- and
intracellular proteolysis mediated by the cysteine cathepsins. Thus,
altered Tg turnover and degradation may  further contribute to the
enhanced levels of TH detectable in thyrocytes of Mct8- and/or
Mct10-deﬁcient mice. Therefore, the status of Tg cross-linking and
degradation was correlated to the amounts of Tg-processing pro-
teases in thyroid tissue of TH transporter-deﬁcient mice, and vice
versa, the expression and localization of the TH transporter Mct8
was determined in thyroid tissue of cathepsin-deﬁcient mice.
3.1. Altered thyroglobulin status in Mct8- and/or Mct10-deﬁcient
mouse thyroid tissue
The Tg status of Mct8 and/or Mct10-deﬁcient thyroid glands was
analyzed morphologically by staining thyroid tissue sections with
antibodies directed against Tg. Luminal Tg depositions are hetero-
geneous but show the typical multilayered appearance (Berndorfer
et al., 1996; Friedrichs et al., 2003) (Fig. 2). Regions representing sol-
ubilized Tg can be identiﬁed by higher immuno-staining intensities,
because these Tg forms are more easily accessible, whereas com-
pact, covalently cross-linked forms of Tg are stained less intense
by the antibodies (Friedrichs et al., 2003). While covalently cross-
linked forms of Tg are prevalent in the centre of follicle lumina, the
soluble and more easily accessible Tg forms are typically detected
next to the apical plasma membrane (Fig. 2, panels A and B, WT;  cf.
panel C). The differences in appearance of luminal Tg-staining thus
depend on the accessibility of Tg for the antibodies, and we used
that effect to quantify the proportion of follicles containing tightly
compacted Tg (Fig. 2C, a, black), multilayered Tg (Fig. 2C, b, grey)
and highly solubilized, multilayered Tg apically with dense, com-
pact Tg in the centre of that follicle (Fig. 2C, c, light grey; diamonds).
Manual counting revealed that there was a trend of a decline
in follicle counts with tightly compacted Tg in Mct8−/y/Mct10−/−
mice (60.8 ± 5.7%) compared to the WT  (87.4 ± 2.5%), while no sig-
niﬁcant differences were observed in Mct10−/− mice (72.0 ± 11.3%)
and in Mct8−/y mice (69.4 ± 7.7%) (Fig. 2, bar charts beneath panel
B). Additionally, follicles with peripheral regions of well-accessible
Tg were not detected in WT  (0.3%) or Mct10−/− mice (0.0%), but 4.3%
of all follicles in Mct8-deﬁcient mice contained those Tg appear-
ances which were even more pronounced in Mct8/Mct10-deﬁcient
animals (9.0%) (Fig. 2, bar charts beneath panel B). Thus, as deduced
from antibody accessibility, Tg states are altered with regard to the
well-accessible Tg appearances in the peri-cellular region at the
apex of thyrocytes, in particular in Mct8−/y and in Mct8−/y/Mct10−/−
mice, indicating more solubilized Tg than in WT  animals (Fig. 2,
panels A and B, cf. Mct8−/y and Mct8−/y/Mct10−/− with WT).
3.2. Thyroglobulin degradation is enhanced in Mct8- and/or
Mct10-deﬁcient mice
To further investigate the effects of TH transporter deﬁciency on
the status of the TH precursor Tg, we analyzed whole thyroid lysates
prepared from young (<2.5 month, see Fig. 3) and adult (5–8 month,
see Fig. 4) mice.
Immunoblots revealed an increase of soluble Tg fragments
(<330 kDa) in young Mct8−/y/Mct10−/− mice compared to all other
genotypes (Fig. 3A and B), and less abundant multimeric forms of Tg
in silver-stained SDS-gels of the same genotype (Fig. 3C), indicating
enhanced solubilization of Tg in Mct8- and Mct10-double-deﬁcient
animals. The presence of more Tg fragments points towards an
enhanced utilization of the TH precursor Tg by thyrocytes upon
deﬁciencies in Mct8 and Mct10. Since a decrease of mono- and
dimeric Tg forms in Mct8−/y/Mct10−/− mice in comparison to Mct8-
deﬁcient mice was  detected under reducing conditions (Fig. 3D),
and at the same time, the soluble dimeric form of Tg was increased
when thyroids lysates were separated under non-reducing condi-
tions (Fig. 3C), it must be assumed that Tg cross-linking is altered in
thyroid follicles of young Mct8- and Mct10-double-deﬁcient mice.
To conﬁrm this interpretation, adult animals were analyzed.
In accordance with the Tg status observed in young animals (see
Fig. 3), signiﬁcantly enhanced amounts of Tg fragments were
detected in both Mct8- and Mct8/Mct10-deﬁcient adult mice when
the protein lysates were separated under reducing conditions
(Fig. 4A). However, it was  found that the effect of increased dimeric
Tg in Mct8/Mct10-deﬁciency of young animals was not present
anymore when thyroid lysates of adult animals were analyzed
under non-reducing conditions (Figs. 4B, cf. 3C). Moreover, Tg mul-
timerization and the amounts of dimeric Tg were observed to occur
to comparable extents in thyroid tissue lysates of all genotypes
analyzed under non-reducing conditions (Fig. 4B), while less di-
and monomeric Tg was observed in Mct8- and/or Mct10-deﬁcient
thyroid tissue lysates in comparison to WT when inspected under
reducing conditions (Fig. 4C).
Thus, gross degradation of Tg is enhanced in Mct8- and/or
Mct10-deﬁcient mice at all ages, while cross-linking for Tg stor-
age is affected primarily in Mct8−/y/Mct10−/− mice at an age of up
to 2.5 months, but by far less prominently altered in 5–8 month old
mice. These results indicate that intra-thyroidal regulation of Tg
turnover affects enzymes involved in cross-linking of Tg (for review,
see Brix et al., 2001) to a lower degree than the proteases involved
in extra- and intracellular processing of Tg for its solubilization and
utilization, eventually resulting in TH liberation.
3.3. Tg-processing proteases are differentially affected by Mct8
and/or Mct10 deﬁciencies
To investigate whether the observed alterations in Tg status
might be due to altered levels of proteolytic enzymes we  analyzed
the protein levels of the cathepsins B, D, and L in thyroid tissue of
young and adult animals. In young mice (<2.5 month), protein levels
of cathepsin B were signiﬁcantly increased in Mct8/Mct10-double-
deﬁcient animals, only (Fig. 5). In adult mice (5–8 months), the
protein amounts of cathepsins B and L in thyroid lysates were sig-
niﬁcantly increased in Mct8- and/or Mct10-deﬁciencies (Fig. 6, top
and bottom panels), whereas cathepsin D protein levels were sig-
niﬁcantly increased in Mct8/Mct10-double-deﬁcient animals, only
(middle panel) when compared to the WT.
Since the localization of proteases, and therefore their possi-
ble access to the substrate Tg, deﬁnes their impact on maintaining
thyroid function, we  used immunohistochemistry to investigate
whether the intra-follicular and subcellular localization patterns
of the cathepsins B, D, and L changed in TH transporter deﬁciency.
Thyroid tissue cryo-sections from WT or Mct8/10-deﬁcient ani-
mals were immunolabeled with antibodies against cathepsin B.
In all genotypes inspected, a staining pattern of largely endocytic
cathepsin B, and, in few follicles, staining in the follicle lumen
as well as at the apical plasma membrane domain of thyrocytes
was observed (Fig. 7A–D). Moreover, the appearance of thyro-
cytes with enlarged cathepsin B positive vesicles in Mct8−/y was
detected (Fig. 7G, arrows), which was  even more prominent in
Mct8−/y/Mct10−/− mice (Fig. 7H, arrows). However, the overall
cathepsin B signal intensity was  increased only slightly in Mct8−/y
and Mct8−/y/Mct10−/− mice when compared to the WT (Fig. 7J).
In WT thyroid epithelial cells, staining of cathepsin D was
restricted to intra-cellular vesicular structures (Fig. 8A and E). The
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Fig. 2. Assessment of Tg states in thyroid follicles of Mct8/Mct10-deﬁcient mice.
Confocal ﬂuorescence images of cryo-sections of thyroid glands from adult WT or TH transporter-deﬁcient mice (5–8 months old) of the indicated genotypes immunolabeled
with  antibodies against Tg. Tg was detected in multilayered form in the follicle lumen of WT mice with increased labelling in proximity to the apical plasma membrane
domain  of thyrocytes, thus indicating soluble forms of Tg (A, asterisks). Abundance of follicles without prominent labelling of soluble Tg (C, a) was decreased in Mct8-
and  Mct8/Mct10-double deﬁcient animals (A and B). Likewise, the proportion of follicles with intensely immuno-labeled soluble Tg (C, b) is increased in Mct8-deﬁcient
animals and even more increased in Mct8/Mct10-double deﬁcient animals. Interestingly, 4.3% and 9.0% of all analyzed follicles of Mct8 or Mct8/Mct10-deﬁcient animals,
respectively, featured highly solubilized Tg (C, c) in the luminal periphery but a dense mass of covalently cross-linked Tg in the central region of large follicles (B, diamond).
A:  representative, overview images used for quantiﬁcation, n = 250, 72, 190, and 127 follicles, respectively. B: close-up images displaying follicles with different forms of Tg.
Bar  charts in B and C: black (a), percentage of follicles without labeled soluble Tg; grey (b), percentage of follicles with labeled soluble Tg; light grey (c), percentage of follicles
with  highly solubilized Tg given as means. Scale bars: 100 m.
signal intensity of cathepsin D staining was elevated in thyroid tis-
sue of Mct10−/−, Mct8−/y and Mct8−/y/Mct10−/− mice (Fig. 8B and F,
C and G, D and H, respectively) when compared to the WT.  Interest-
ingly, cathepsin D positive vesicles in Mct8- and/or Mct10-deﬁcient
mice appeared larger than those of the respective WT  controls
and in some cases, vesicles with prominently enhanced diameters
were found (Fig. 8F–H, cf. E, dashed arrows). A striking difference
between Mct8−/y and Mct8−/y/Mct10−/− mice was  the occurrence
of cathepsin D staining at the basal surface of thyrocytes, which
could either be due to cathepsin D staining in endothelial cells
(Fig. 8G, asterisks), secretion of cathepsin D at the basal pole, and
its re-association with the basolateral plasma membrane domains
of thyrocytes (arrows), or both.
In WT animals, cathepsin L is localised in vesicular structures,
but in few follicles, association with the apical plasma membrane
domain of thyrocytes was also observed (Fig. 9A). In Mct10-
deﬁcient mice, the localization of cathepsin L did not change when
compared to the WT  control, however a slight increase of signal
intensity was  measured indicating elevated protein expression lev-
els (Fig. 9B and H). In Mct8−/y and Mct8−/y/Mct10−/− mice, cathepsin
L was detected intracellularly within vesicular structures that were
much larger than those in WT  tissue, in some cases reaching diam-
eters comparable of the nuclei of the respective cells, i.e. up to
6 m (Fig. 9C and D, E and F, E’ and F’, arrows). Additionally, local-
ization of cathepsin L at the apical plasma membrane domain of
Mct8−/y/Mct10−/− thyrocytes was  increased and luminal staining
next to the apical plasma membrane domain was  much more abun-
dant than in the WT (Fig. 9F, cf. E, arrows).
The data from immunoﬂuorescence staining of thyroid tissue
(Figs. 7–9) conﬁrmed the immunoblotting results (Fig. 6) such that
cathepsin B protein levels were increased in thyroid lysates of
Mct8−/y and Mct8−/y/Mct10−/− animals, while cathepsin L protein
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Fig. 3. Thyroglobulin degradation pattern and cross-linkage in <2.5 months old mice.
Whole thyroid lysates of WT mice or mice deﬁcient in Mct10, Mct8 and/or Mct10 were separated on horizontal SDS-gels, silver-stained or transferred to nitrocellulose for
subsequent incubation of the blots with antibodies against Tg as indicated, and compared to the WT.  (A) Shown is a representative immunoblot with the indicated genotypes.
(B)  Low molecular mass fragments of Tg are representative of degradation products which were revealed by densitometry to be signiﬁcantly increased in Mct8/Mct10-deﬁcient
animals. (C) Under non-reducing conditions, the amounts of the soluble form of Tg are increased in Mct8/Mct10-deﬁcient animals, whereas the multimeric Tg forms were less
abundant compared to the WT,  Mct10- and Mct8-deﬁcient animals. Mct8-deﬁcient mice were observed to have more total Tg amounts including the multimeric form. Upon
reducing samples with DTT before SDS-PAGE, the persistence of dimeric Tg was  reduced in Mct8/Mct10-deﬁcient animals (E), thus indicating altered solubilization of Tg,
whereas Mct8-deﬁcient animals featured increased dimeric and monomeric Tg when compared to the WT.  Animals analyzed: n = 5, 3, 5, and 5, respectively. In B, means ± SD
are  given; *, P < 0.05; **, P < 0.005.
levels were enhanced in thyroid tissue of all genotypes, and most
prominently in Mct8−/y/Mct10−/− mice, which were further charac-
terized by enhanced amounts of cathepsin D. Thus, the data point to
most signiﬁcantly enhanced amounts of endo-lysosomal cathepsin
L in particular in Mct8−/y and Mct8−/y/Mct10−/− mouse thyrocytes,
i.e. in the animal models featuring the most severe intra-thyroidal
thyrotoxic states (Muller et al., 2014). Considering cathepsin L’s
main function in Tg processing, the enhanced amounts of this
protease in Mct8−/y/Mct10−/− thyroid tissue explain the largely
enhanced extent of Tg degradation observed in Mct8/Mct10-
deﬁcient mice (Figs. 3 and 4), and suggest that T4 accumulates in
thyrocytes of these animals. Thus, the enhanced amounts of cathep-
sin L, which is also vital for T4 liberation from Tg, in thyroids of mice
lacking the TH-transporting Mct8, which is mainly responsible for
T4 release from thyroid follicles, is counterintuitive.
3.4. A lack of the T4-liberating cysteine cathepsin K is associated
with enhanced amounts of the main T4-exporting transporter
Mct8
The cysteine cathepsins K and L together are critical for TH
liberation (see Table 1; Friedrichs et al., 2003). Cathepsin K, in par-
ticular, mediates direct liberation of T4 from Tg (Tepel et al., 2000).
A loss of cathepsin K can be compensated by other cathepsins; this
notion was  derived from analyses of mice shortly after establish-
ing the Ctsk−/− model, i.e. when the animals were still on a mixed
129Ola:C57BL/6J background (Friedrichs et al., 2003). However, in
this study, we  used congenic animals on the C57BL6/J background.
Immunoblotting revealed that the loss of cathepsin K led to an
increase of cathepsin L expression, whereas protein amounts of
cathepsins B and D were not, or only marginally elevated in Ctsk−/−
when compared to WT  controls (Fig. 10). These data conﬁrmed our
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Fig. 4. Thyroglobulin degradation pattern and cross-linkage in 5–8 months old mice.
Whole thyroid lysates of mice deﬁcient in Mct10, Mct8 and/or Mct10 were separated on vertical or horizontal SDS-gels, silver-stained or transferred to nitrocellulose
for  subsequent incubation of the blots with antibodies against Tg, as indicated, and compared to the WT.  (A) Displayed is a representative immunoblot result and the
corresponding densitometry data showing increased amounts of smaller Tg fragments, with molecular masses below 330 kDa, in Mct8- and/or Mct10-deﬁcient mice as
compared to the WT mice. (B) When separating whole thyroid lysates in non-reducing conditions, the band of the dimeric Tg was comparable in all genotypes investigated,
however the multimeric forms of Tg were less abundant in Mct8- and Mct8/Mct10-deﬁcient mice. (C) Reducing samples with DTT before SDS-PAGE yielded in decreased
intensity of bands representing the mono- and dimeric Tg in Mct8- and/or Mct10-deﬁcient animals, however most striking in Mct8- and Mct8/Mct10-deﬁcient mice, which
may  indicate increased solubilization and proteolytic degradation of Tg by cysteine cathepsins. Animals analyzed: n = 2–3. In A, means ± SD are given; *, P < 0.05.
previous ﬁndings (Friedrichs et al., 2003), and further validated the
importance of cathepsin L-mediated Tg processing.
Loss of both cathepsins K and L leads to decreased T4 levels in the
blood; however, loss of cathepsin K alone does not affect serum TH
levels (Friedrichs et al., 2003). While endo-lysosomal Tg process-
ing is compensated for in Ctsk−/− mice by cathepsin L, the function
of cathepsin K in extracellular T4 liberation directly from Tg is still
lacking, leading us to wonder how normal serum T4 levels are main-
tained in Ctsk−/− mice. We  reasoned that one possible mechanism
explaining normal serum TH levels may  be an upregulation of TH
transporters, and to this extent we investigated Mct8 expression in
thyroids of Ctsk−/− mice.
The signal detected after incubation of cryo-sections with anti-
bodies against Mct8 (Fig. 11A and B) was quantiﬁed, and a 3-fold
increase in thyroid tissue of Ctsk−/− animals was found (Fig. 11F).
Likewise, in immunoblots, Mct8 protein amounts were found to
be increased in thyroid tissue lysates of cathepsin K-deﬁcient over
WT animals (Fig. 11G and H). However, the localization of Mct8 at
the basolateral plasma membrane domain of the thyrocytes did not
change in Ctsk−/− animals (Fig. 11D and E).
As described above, alterations in the levels of TH trans-
porters feedback on the gross degradation of Tg mediated by
endo-lysosomal proteases (see Figs. 3 and 4). Therefore, we fur-
ther investigated whether the reverse situation, namely a loss of
the Tg-degrading cathepsins B and L, is accompanied by different
expression of the TH transporter Mct8. In mice with single-
deﬁciencies in the cathepsins B or L, or in cathepsin B- and
K-double-deﬁcient animals, similar observations were made, as
such, that Mct8 staining intensities were increased over WT,  but
its localization at the basolateral plasma membrane domain of
thyrocytes did not change (Fig. 12). However, anti-Mct8-positive
puncta were additionally observed in the cytoplasm of thyrocytes
of cathepsin B-, K-, or L-single- and cathepsin B/K-double-deﬁcient
mice (Fig. 12, arrows).
Thus, the notion of enhanced amounts of the T4-exporting Mct8
in conditions of Tg-processing cathepsins lacking from mouse thy-
roid epithelial cells (this study) is counterintuitive, as it most likely
means that the thyroid gland itself becomes hypothyroid, especially
in the absence of the T4-liberating cathepsin K (Tepel et al., 2000;
Friedrichs et al., 2003), in order to maintain proper serum levels of
TH. The blood serum must therefore be viewed as a sink for free T4
(Heuer and Visser, 2013).
4. Discussion
Keeping in mind that the thyroid itself is a target of the hor-
mones it produces, regulation of the process of liberation and
release of TH is crucial to overall thyroid function (Brix et al.,
2011; Dauth et al., 2011). It is well known that thyroid gland
tasks are directed by the HPT axis (Nussey and Whitehead, 2001).
Thus, to prevent TH over-production, circulating TH carry out
negative feedback by blocking TSH release from the anterior pitu-
itary and decreasing the production of TRH by the hypothalamus.
However, regulation through the HPT axis is largely impaired in
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Fig. 5. Protein levels of cathepsin B, D, and L in thyroids of TH transporter-deﬁcient young mice.
Whole thyroid lysates of young mice (less than 2.5 months old) were separated on horizontal SDS-gels, transferred to nitrocellulose and incubated with antibodies against
the  respective proteins (left panels). Densitometry of the immunolabeled bands revealed that cathepsin B, D, and L levels were elevated signiﬁcantly in Mct8/Mct10-deﬁcient
animals, however thyroid lysates of Mct8- or Mct10-deﬁcient animals did not exhibit elevated protein amounts when compared to the WT  (right panels). Animals analyzed:
n  = 6, 3, 6 and 10, respectively. HC = heavy chain; SC = single chain; pro = pro form. Data are given as means ± SD; ***, P < 0.001.
Fig. 6. Protein levels of cathepsin B, D, and L in thyroids of TH transporter-deﬁcient adult mice.
Whole thyroid lysates of adult mice (5–8 months old) were separated on horizontal SDS-gels, transferred to nitrocellulose and incubated with antibodies against cathepsins B,
D  or L (left panels). Densitometry of the indicated bands revealed that cathepsin D protein levels were elevated signiﬁcantly in Mct8/Mct10-deﬁcient mice, whereas cathepsin
B  and L levels were increased in all investigated genotypes when compared to WT (right panels). Animals analyzed: n = 3 per genotype. HC  = heavy chain; SC = single chain;
pro  = pro form. Data are given as means ± SD; *, P < 0.05; **, P < 0.005.
TH-resistant Mct8- and Mct8/Mct10-deﬁcient mice (Trajkovic et al.,
2007; Muller et al., 2014). In this study, we propose that TH trans-
porters like Mct8 and Mct10 collectively meet the demands of
facilitating the release of TH into the blood in order to properly
support peripheral TH target organs, while also involving in intra-
thyroidal TH sensing that affects the amounts and localization
of Tg-processing proteases, and thereby, contributes to auto-
regulation of the functional activities of thyrocytes. Indeed, the
thyroid gland of mice lacking globally the TH transporters Mct8 and
Mct10 is characterized by high amounts of the Tg-processing cys-
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Fig. 7. Expression and localization of cathepsin B in thyroid glands from TH transporter-deﬁcient mice.
Cathepsin B (white, red) was  mainly localised in vesicles of thyrocytes of WT  (A) and Mct10- (B) Mct8- (C), and Mct8/Mct10-deﬁcient (D) animals but also associated with
the  apical plasma membrane domain and within the lumen of thyroid follicles (E to H, asterisks). Thyroid tissue taken from cathepsin B-deﬁcient animals served as controls
for  antibody speciﬁcity, which was conﬁrmed by lack of primary antibody reactivity (I). Vesicular staining (arrows) of cathepsin B is more pronounced and signal intensities
(J)  are slightly increased in both, Mct8- (G) or Mct8/Mct10-deﬁcient (H) mouse thyroids when compared to WT (E). Representative images of 3 animals (5–8 months old)
per  genotype are displayed. J: normalized signal intensity per cell given as means ± SD; n = 12, 8, 8, and 12, respectively. Nuclei were counter-stained with Draq5TM (blue). L
denotes  follicle lumen. Scale bars: 50 m (A–D, I) and 25 m (E–H).
teine cathepsins, while the reverse situation, cathepsin deﬁciency,
results in up-regulated T4-exporting capabilities of thyrocytes,
since Mct8 is present in enhanced amounts. Although counterintu-
itive, this notion contributes to explanations, why Mct8 deﬁciency
leads to intra-thyroidal hyperthyroid states and to the unusual thy-
roid states in the blood circulation (see below; Müller and Heuer,
2014). In stark contrast, single deﬁciencies in the cathepsins B, K,
and L feature eu- or only very mildly hypothyroid states (Friedrichs
et al., 2003). Cathepsin K and L double-deﬁciency, only, results in
hypothyroidism in mice (Friedrichs et al., 2003).
4.1. Thyroid function is maintained by TH release from thyroid
follicles which is enabled by protease-mediated TH liberation from
Tg
Mct8 knock-out mice exhibit an unusual pattern of altered
TH serum levels with low T4 and highly increased T3 levels
(Dumitrescu et al., 2006; Trajkovic et al., 2007; Wirth et al., 2011).
Animals lacking both Mct8 and Mct10 exhibit partially normalized
serum T4 levels, despite TSH levels elevated over WT  to an extent
comparable to Mct8-deﬁcient mice, but the elevated T3 serum lev-
els typical for Mct8-deﬁcient mice are maintained (Muller et al.,
2014). The reason for these highly unusual serum TH states are
considered to reside in decreased T4 release from thyroid follicles
due to dysfunctional Mct8-facilitated export across the basolateral
plasma membrane domain of thyrocytes (Muller et al., 2014). In the
same animals, increased conversion of T4 to T3 mediated by deiod-
inase 1 (Dio1) in liver and kidney explains the abnormally high T3
serum levels. In addition, we believe that the thyroid gland of Mct8
knock-out mice releases more T3 due to intact Mct10-facilitated
transport, which contributes further to the unusually high T3/T4
ratios in the blood of Mct8-deﬁcient mice (Muller et al., 2014).
Previously, an enlargement of thyroid follicles was found in
mice with deﬁciencies in Mct8 alone, or in Mct8 and Mct10 (Di
Cosmo et al., 2010; Trajkovic-Arsic et al., 2010b; Wirth et al., 2011;
Muller et al., 2014). Moreover, transcript levels of the thyroid-
speciﬁc genes coding for the sodium-iodide symporter NIS, the
thyroid peroxidase TPO, and for the TH precursor protein Tg are
increased in Mct8-deﬁcient mice, and this increase was even
more pronounced in Mct8/Mct10-double deﬁciency (Muller et al.,
2014). Although TSH levels are similar in both mouse models,
it is not yet known in how far bioactivity of TSH is altered in
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Fig. 8. Expression and localization of cathepsin D in thyroid glands from TH transporter-deﬁcient mice.
Cathepsin D was localised in vesicles distributed evenly throughout the cytoplasm in thyrocytes of WT (A), Mct10- (B), Mct8- (C), and Mct8/Mct10-deﬁcient (D) mice.
Enlarged anti-cathepsin D-positive vesicles where found in Mct10- (F), Mct8- (G), and Mct8/Mct10-deﬁcient (H) mice (dashed, empty arrows) when compared to the WT (E).
In  Mct8-deﬁcient mice, cathepsin D staining was observed at the basal surface of thyrocytes (G, arrows), or at the plasma membrane domain of endothelial cells (G, asterisks).
Dotted lines (E-H) represent outlines of follicle epithelia. Representative images of 3 animals (5–8 months old) per genotype are displayed. L denotes follicle lumen. Scale
bars:  50 m (A–D) and 10 m (E–H).
the TH transporter-deﬁcient mice. Indeed, it is likely that Mct8-
deﬁcient thyrocytes are stimulated more strongly than thyroid
follicle cells of Mct8/Mct10-double deﬁcient mice, because TRH lev-
els are higher in Mct8-deﬁcient animals (Muller et al., 2014). Thus,
intra-thyroidal TH production and TH liberation from Tg is most
likely de-regulated differently in Mct8−/y and Mct8−/y/Mct10−/−
animals. Therefore, we investigated the Tg status and the molec-
ular pathways of Tg utilization for TH liberation by analyzing the
key players involved in proteolytic processing and degradation of
Tg, the cathepsins (see Table 1 and Fig. 1).
The data collected in this study by inspecting the Tg status of
TH transporter-deﬁcient mice (see Figs. 2–4), suggests that both Tg
solubilization from covalently cross-linked storage forms by extra-
cellular Tg processing, and its utilization for TH liberation by extra-
and intracellular means of proteolytic Tg degradation are enhanced
in Mct8- and/or Mct10-deﬁciencies. Therefore, we  postulated that
Tg-processing enzymes may  be differently expressed and localised
in thyroid tissue of Mct8- and/or Mct10-deﬁcient mice.
Secretion of cathepsin B at the apical pole of thyrocytes is
increased upon acute TSH stimulation, i.e. 1–2 h after TSH stimu-
lation, whereas enhanced biosynthesis of cathepsin B will occur
only during long-term chronic TSH stimulation (Linke et al.,
2002a,b). Accordingly, because the elevated TSH levels in Mct8-
or Mct8/Mct10 animals are chronic (Di Cosmo et al., 2010; Muller
et al., 2014), we expected increased protein levels of cathepsin
B, which were indeed observed by immunoblotting (see Fig. 6).
Moreover, the intra-follicular localization of cathepsin B differed
from WT,  in particular in Mct8- and Mct8/Mct10-deﬁcient mice,
such that the protease was  almost exclusively present in enlarged
endo-lysosomes of the thyroid epithelial cells (see Fig. 7).
Another important protein that is involved in endo-lysosomal Tg
degradation, but less so in TH liberation from Tg, is the aspartic pro-
tease cathepsin D (Dunn et al., 1991; Jordans et al., 2009). In mouse
thyrocytes, cathepsin D is usually localised in vesicles distributed
throughout the cytoplasm and accumulating in the perinuclear
region, i.e. in lysosomes of thyrocytes (Friedrichs et al., 2003). In
this study, cathepsin D was found in immensely enlarged endo-
lysosomal vesicles of Mct8- and Mct8-/Mct10-deﬁcient mouse
thyrocytes (see Fig. 8), indicating enhanced abilities of these follicle
cells to completely degrade Tg by intracellular means of lysosomal
proteolysis. Moreover, cathepsin D was found to be secreted from
thyrocytes of Mct8-deﬁcient mice at the basolateral pole. This ﬁnd-
ing is interesting when considering the role that cathepsin D plays
in cancer (Brix et al., 2008; Brix et al., 2015). Mct8-deﬁcient mice
develop papillary thyroid carcinoma (PTC) at older age, possibly
due to a loss of auto-regulative control of thyrocyte proliferation
(Wirth et al., 2011). However, basolaterally secreted cathepsin D
may  further contribute to the progression of PTC development as
it can, in principle, enhance extracellular matrix degradation, and
thereby facilitate cancer progression.
Cathepsin L plays a vital role in thyrocyte function, and it was
shown to be important for survival of thyrocytes, since the respec-
tive knock-out models showed luminal inclusions of dead cells and
dead cell remnants (Friedrichs et al., 2003). Here we show that the
availability of cathepsin L in the extracellular follicle lumen is more
pronounced in Mct8/Mct10-deﬁcient mice than in Mct8−/y mice
(see Fig. 9), suggesting enhanced Tg solubilisation for subsequent
endocytic uptake. In addition, this enzyme with a critical function
in maintaining proper serum levels of T4 (Friedrichs et al., 2003)
was enhanced in protein amounts, in particular, in Mct8 and Mct10
deﬁcient mouse thyrocytes.
Hence, the protein levels of the Tg-processing proteases corre-
late with the lack of TH transporter proteins like Mct8 and/or Mct10.
These observations most likely contribute to explaining why  among
the TH transporter-lacking genotypes inspected in this study, espe-
cially the Mct8−/y/Mct10−/− mouse model features the most severe
auto-thyrotoxic states (Muller et al., 2014). In reverse, the main
T4-exporting transporter molecule Mct8 is up-regulated in Ctsk−/−
mice, a Tg processing enzyme that is able to directly liberate T4
from its protein precursor molecule Tg by extra- and intracellu-
lar means of proteolysis (Tepel et al., 2000). In addition, cathepsin
L is up-regulated in the thyroid of Ctsk−/− mice (Friedrichs et al.,
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Fig. 9. Expression and localization of cathepsin L in thyroid glands from thyroid hormone transporter deﬁcient animals.
Cathepsin L was detected in vesicular structures in all genotypes (A, B, C, and D), except in tissue from cathepsin L-deﬁcient mice (G), which served as control for antibody
speciﬁcity. Few follicles of WT (A) and Mct10-deﬁcient (B) animals showed apical and luminal cathepsin L staining, however intensities of cathepsin L labelling (H) were
increased in Mct8 and/or Mct10-deﬁcient mice (B and C) when compared to WT animals (A). Note the increased luminal, apical and vesicular staining patterns and intensities
of  cathepsin L (green) in thyrocytes of Mct8/Mct10-deﬁcient animals (F) compared to the WT (E), and in the respective higher magniﬁcations (E’ and F’). Representative
images of 3 animals (5–8 months old) per genotype are displayed. Nuclei were counter-stained with Draq5TM (blue). H: normalized signal intensity per cell; mean +/− SEM;
n  = 1193, 1422, 1309, and 1638, respectively. L denotes follicle lumen. Scale bars: 50 m (A–D, G) and 10 m (E, F). *, P < 0.05.
2003), which also feature enhanced Mct8 at the basolateral plasma
membrane domains of thyrocytes (this study).
Such correlations between TH-liberating proteases and TH
transporters are somewhat counterintuitive, and indicate a loss of
TH sensing capabilities of thyrocytes upon functional loss of either
key-player enabling thyroid gland functions (see Fig. 13).
4.2. Thyroid auto-regulation tolerates minor changes in thyroid
states by redundancy, but a self-destructive vicious cycle is
switched on when the key-players cathepsin L and Mct8 are
affected by disease
Physiologically, we  suggest that thyrocytes can counter-act
minimal functional disbalances of thyroid states by up-regulation
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Fig. 10. Protein levels of cathepsins B, D, and L in thyroids of cathepsin K-deﬁcient mice.
Whole thyroid lysates were separated on horizontal SDS-gels, transferred to nitrocellulose and incubated with antibodies against the respective proteins. (A) Immunoblots
of  cathepsins B, D, and L were quantiﬁed by densitometry (B). Cathepsin L levels were elevated signiﬁcantly in Ctsk-deﬁcient animals. Animals analyzed: n = 3 per genotype.
HC  = heavy chain; SC = single chain. Data are given as means ± SD; *, P < 0.05.
of TH transporters (as in Ctsb−/−, Ctsk−/−, Ctsl−/−, or Ctsb−/−/Ctsk−/−
mice), or by enhancing cathepsin-mediated Tg-processing (as in
Ctsk−/− mice), or both, without the necessity of TSH-triggered
classical regulation (see Fig. 13). Such auto-regulatory pathways,
driven exclusively by intra-thyroidal means, might be based upon
thyrocyte-speciﬁc measures of TH-sensing. Thus, within thyroid
follicles, the thyroid epithelial cells detect the amounts of TH lib-
erated, and integrate these with those TH amounts exported from
the follicles for global supply (Fig. 13, WT). Such a pathway of TH-
sensing within thyroid epithelial cells of individual follicles most
likely requires the involvement of TH transporters acting at differ-
ent cellular membranes (Fig. 13). Interestingly, although different
TH transporter proteins are expressed in mouse thyrocytes (Di
Cosmo et al., 2010), compensatory up-regulation of TH transporters
in Mct8-deﬁcient animals has not been found (Di Cosmo et al., 2010;
Wirth et al., 2011). In contrast, enhanced Tg degradation and uti-
lization takes place when Mct8 and Mct10 are lacking (this study).
Eventually, this leads to increased intra-thyroidal TH levels, which
should feedback to the thyrocyte to stop the elevation of TH produc-
tion at one point. Ironically, and against all logics, such a regulatory
feedback does not happen in Mct8/Mct10-deﬁcient animals.
In summary, the results of this study provide a molecular mech-
anistic explanation for the altered thyroid functional states of mice
with Mct8- and/or Mct10-deﬁciencies in that enhanced Tg degra-
dation by cathepsins B and L (acting extra- and intracellularly on Tg)
and by intra-lysosomally acting cathepsin D occurs, although this is
counterintuitive and likely worsens the intra-follicular thyrotoxic
states.
At ﬁrst glance, up-regulation of Mct8 in thyroid glands
of animals lacking the Tg-processing cathepsin proteases
(Figs. 11 and 12) makes more sense as the export of T4 from
the thyroid follicles would be facilitated in such conditions of
enhanced Mct8 at the basolateral plasma membrane of thyrocytes.
However, again counterintuitively, the thyroid gland itself might
become hypothyroid, at least transiently, at the expense of main-
taining proper TH supply to the peripheral organs, in particular, in
Ctsk−/− mice (Friedrichs et al., 2003). Within the thyroid follicles of
Ctsk−/− mice, such states of too little TH liberation due to lacking
cathepsin K-mediated Tg-processing by extra- and intracellular
means of proteolysis are obviously sensed and counter-acted such
that they eventually lead to a compensatory up-regulation of the
amounts of cathepsin L (Friedrichs et al., 2003).
4.3. Perspectives
In conclusion, we propose that the intra-thyroidal TH sens-
ing mechanisms present in Ctsb−/−, Ctsk−/−, Ctsl−/−, Mct8−/y, and
Mct8−/y/Mct10−/− mice are enabled such that different TH trans-
porters are present in speciﬁc subcellular locations of thyroid
epithelial cells, thereby selectively monitoring individual steps
of thyroglobulin processing and thus, the cellular TH status (see
Fig. 13). Hence, future studies must elucidate the molecular nature
of these proposed intra-thyroidal T4-sensing mechanisms beyond
Mct8, in order to unravel, how T4-sensing by Mct8 and/or Mct10 at
the basolateral plasma membrane domain is mechanistically con-
nected to regulation of translation and trafﬁcking of Tg-processing
proteases within individual follicles, and how precisely the associ-
ation with endo-lysosomal functions is maintained. We  propose
an involvement of the TH transporter Lat2, which is present at
the endo-lysosomal membrane of thyrocytes in WT mice (McInnes
et al., 2013; Weber et al., 2015).
The involvement of the HPT-axis on such intra-thyroidal, regu-
latory pathways is most likely mild, but must still be considered,
because TSH affects both, short-term trafﬁcking and long-term
translational regulation of Tg-processing abilities (Linke et al.,
2002a,b), besides regulating the differentiated state of thyrocytes
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Fig. 11. Mct8 expression levels and localization in thyroid tissue of cathepsin K-deﬁcient mice.
Signal intensities were quantiﬁed in micrographs of cryosections labeled with antibodies against Mct8 (A, B). Tissue of Mct8-deﬁcient animals served to control for staining
speciﬁcity of the primary antibody (C). Note the signiﬁcant increase of Mct8 in cathepsin K-deﬁcient mice when compared to the WT  (F). However, the localisation of Mct8
(green)  at the basolateral plasma membrane domain (D and E) did not change in cathepsin K-deﬁciency. Whole thyroid lysates were separated on horizontal SDS-gels,
transferred to nitrocellulose for subsequent incubation of the blots with antibodies against Mct8 (G) and the quantiﬁcation by densitometry revealed elevated Mct8 levels
in  Ctsk-deﬁcient mice (H). F: animals analyzed were 8 and 9, respectively; data are given as means ± SD; n = 41 and 49 follicles, respectively. H: animals analyzed n = 6, and
6,  respectively. Scale bars: 40 m (A–C) and 10 mm (D and E). Nuclei were counter-stained with Draq5TM (blue). ***, P < 0.001.
and Tg biosynthesis (Brix et al., 2001). Thus, it will be important in
future studies to discriminate between TSH-dependent regulation
and thyroid auto-regulation that is independent of the systemic
HPT-axis. In this regard, we are currently analyzing knock-out mod-
els featuring thyroid-speciﬁc Mct8-deﬁciency.
Lastly, it would be interesting to include studies on the Tg cross-
linking mechanisms and the enzymes involved, with the aim to
compare those in global versus thyroid-speciﬁc Mct8-deﬁciencies.
In this context, it should be noted that, although Tg cross-linking
in mice is under-explored, Tg folding must be considered a prereq-
uisite for Tg trafﬁcking along the secretory route and its exocytotic
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Fig. 12. Mct8 expression levels and localization in thyroid tissue of WT  and cathepsin B, K, L, and B/K-deﬁcient mice.
Confocal ﬂuorescence micrographs of cryosections labeled with antibodies against Mct8 (green) revealed enhanced staining intensity in cathepsin-deﬁcient mice (B–E) when
compared to the WT (A). However, the localization of Mct8 at the basolateral plasma membrane domain did not change in cathepsin-deﬁciencies. Thyroid of cathepsin-
deﬁcient mice were characterized by anti-Mct8-positive puncta (arrows) which were most abundant in Ctsl−/− (D) and Ctsb−/−/Ctsk−/− (E) mice. Scale bars: 10 m. Nuclei
were  counter-stained with Draq5TM (blue).
Fig. 13. The inﬂuence of cathepsin K and TH transporter deﬁciency on liberation of TH and their release from thyroid follicles.
Tg  is synthesised and secreted at the apical plasma membrane of thyrocytes (WT, left) to be stored in covalently cross-linked form in the lumen of thyroid follicles. Upon
TSH  stimulation, cysteine cathepsins are secreted upon retrograde trafﬁcking, and cathepsins B and L are involved in solubilization of Tg, whereas cathepsin K is involved in
direct  T4 liberation in the follicle lumen (WT, upper portion, and lower panel), which may  be transported across the apical plasma membrane domain by an as yet unknown
T4  transporter (cyan). Then, Tg and partially degraded Tg molecules are endocytosed for delivery to early and late endosomes as well as lysosomes, where T4 and T3 can be
liberated  by the intracellular proteolytic action of cysteine cathepsins before being transported across the endo-lysosomal membranes into the cytosol (dark pink). T4 may
then  be deiodinated and thus activated to T3, or T4 is released from the thyrocytes by transport across the basolateral plasma membrane domain (chartreuse).
Mice  deﬁcient in cathepsin K exhibit normal T4 serum levels, while Mct8 deﬁciency results in reduced T4 and slightly elevated serum TSH concentrations. TSH inﬂuences the
increase of TH production and likewise, expression of cathepsins is elevated upon long-term TSH stimulation (Linke et al., 2002b). Mice with deﬁciencies in Mct8 and Mct10
exhibit  similar TSH levels as Mct8-deﬁcient mice but different serum T4 levels. Upon loss of cathepsin K (Ctsk−/−), we observed up-regulated cathepsin L expression and
activity (Friedrichs et al., 2003; red arrows) and enhanced expression of the TH transporter Mct8 at the basolateral plasma membrane domain of the thyrocytes (this study;
green  arrows), suggesting T4 release from thyroid follicles to be favored over self-sustaining regulation, thereby rendering the thyroid gland hypothyroid. Upon loss of both
Mct8  and Mct10 (Mct8−/y/Mct10−/−), we observed altered cross-linking and multimerization of Tg which may  have led to enhanced utilization of Tg for TH liberation (red
arrows) and thereby increasing the intra-thyroidal TH levels (Muller et al., 2014). We speculate that the loss of Mct8 (green crosses) and Mct10 from the basolateral plasma
membrane domain of thyrocytes led to a loss of sensing capability for the amount of liberated TH by cathepsins, which yielded in increased processing and degradation of
Tg  despite toxic intra-thyroidal TH concentrations, thereby however also contributing to the normal serum T4 levels in Mct8/Mct10-deﬁcient mice.
release from thyrocytes, before Tg is eventually stored in cross-
linked form in the thyroid follicle lumen. Both, Tg folding and
Tg cross-linking are chaperoned and mediated by protein disul-
ﬁde isomerase (PDI; Berndorfer et al., 1996; Muresan and Arvan,
1998; Di Jeso and Arvan, 2016), at least in humans. However,
Tg may  also undergo self-assisted disulﬁde bond formation due
to the thioredoxin-boxes present in the N-terminal half of the
molecule (Klein et al., 2000; Schmitz et al., 2002). Interestingly,
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the Tg molecule further features the presence of different internal
homology domains (for review, see Brix et al., 2001), some of which
contain the aforementioned CXXC-motifs of thioredoxins, while
others are characterized by CWCV-motifs that are indicative of the
so-called thyropins, i.e. small proteins or peptides acting as cysteine
peptidase inhibitors (Lenarcic et al., 1997). Clearly, future studies
are needed in mice to explore the signiﬁcance of Tg cross-linking
and the possible interconnections with its degradation, since both
are potentially subject to intra-thyroidal auto-regulation, i.e. by Tg
itself (Rousset and Mornex, 1991; Brix et al., 2001).
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